Related Experiment Video
Updated: Sep 13, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Correlation and Risk Assessment of Inflammation-Based Parameters on Cardiovascular Parameters and Clinical Events in
Leyla Schweiger1, Andreas Meinitzer2, Dieter Szolar3
1Division of Angiology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
Insights
In patients with inactive giant cell arteritis (GCA), elevated white blood cells and neutrophils correlate with endothelial dysfunction and predict disease relapse. Other inflammatory markers did not predict cardiovascular events or mortality.
Area of Science:
- Rheumatology
- Immunology
- Cardiovascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
- Endothelial dysfunction and lipid abnormalities are common in GCA.
- Inflammation-based biomarkers may offer insights into GCA pathogenesis and prognosis.
Purpose of the Study:
- To investigate associations between inflammation biomarkers, endothelial dysfunction, and lipids in GCA.
- To determine the predictive value of these biomarkers for clinical outcomes in GCA patients.
Main Methods:
- Retrospective analysis of 138 patients with inactive GCA.
- Assessment of inflammatory biomarkers, endothelial dysfunction markers, and lipid parameters.
- Logistic regression analysis to evaluate predictive value for clinical outcomes.
Main Results:
- Higher white blood cell and neutrophil counts were observed in GCA patients without polymyalgia rheumatica symptoms or those receiving initial glucocorticoid pulse therapy.
- Significant correlations were found between inflammation-based ratios, endothelial dysfunction markers, and lipid parameters.
- Elevated white blood cells and neutrophils independently predicted disease relapse in GCA patients.
Conclusions:
- Selected inflammatory parameters correlate with endothelial dysfunction and dyslipidemia in inactive GCA.
- White blood cells and neutrophils are significant predictors of disease relapse in GCA.
- No significant associations were found between inflammatory biomarkers and cardiovascular events, mortality, or glucocorticoid adverse effects.
Abstract:
This study investigated associations of inflammation-based biomarkers with endothelial dysfunction and lipids and their predictive value for clinical outcome parameters in patients with giant cell arteritis (GCA). A total of 138 patients with inactive GCA were retrospectively analyzed to investigate potential differences in inflammatory biomarkers regarding clinical GCA subtypes and potential correlations between inflammatory parameters with markers of endothelial dysfunction and lipid parameters. Additionally, the predictive role of inflammatory biomarkers for clinical outcomes, including disease relapse, all-cause mortality, cardiovascular events, and glucocorticoid adverse effects, was analyzed. GCA individuals without concomitant symptoms of polymyalgia rheumatica and those who received initial glucocorticoid pulse therapy exhibited significantly higher levels of white blood cells and neutrophils (all with p < 0.05). No other significant differences were observed between inflammatory biomarkers and clinical GCA subtypes. Additionally, significant correlations were identified between selected inflammation-based ratios and specific markers of endothelial dysfunction and lipid parameters (all with p < 0.05). Elevated white blood cells and neutrophils were significant and independent predictors of disease relapse in GCA (all with p < 0.05) in multiple logistic regression analysis. No significant associations were found between any other inflammatory biomarker and the occurrence of cardiovascular events, mortality, or glucocorticoid-related adverse effects. In patients with inactive GCA, selected inflammatory parameters correlated with endothelial dysfunction and dyslipidemia and may be predictive of disease relapse.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

